TITLE

The use of glucagon in acute esophageal food impaction (EFI): how often does it work?

AUTHOR(S)
Ferguson, Dawn D; Ward, Eric M; Raimondo, Massimo
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS10
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "The Use of Glucagon in Acute Esophageal Food Impaction (EFI): How Often Does it Work?," by Dawn D. Ferguson, Eric M. Ward and Massimo Raimondo is presented.
ACCESSION #
66954543

 

Related Articles

  • Use of Lucozade and glucagon by ambulance staff for treating hypoglycaemia. Steel, J.M .; Allwinkle, J.; Moffat, R.; Carrington, D.J. // BMJ: British Medical Journal (International Edition);5/16/92, Vol. 304 Issue 6837, p1283 

    Examines the use of Lucozade and glucagon on patients with hypoglycemia in Lothian, Scotland. Association between intensive treatment with insulin and the prevalence of the disease; Efficacy of ambulance staff in measuring blood glucose concentrations and in treating the disease.

  • Diagnostic Use of Glucagon--Induced Insulin Response. Kumar, Dinesh; Mehtalia, Suresh D. // Annals of Internal Medicine;Jun74, Vol. 80 Issue 6, p697 

    Presents a study which assessed the intravenous glucagon stimulation test as a diagnostic tool in the differential diagnosis of hypoglycemia. Methodology; Results; Discussion.

  • The Design and Biological Activities of Glucagon Agonists and Antagonists, and their Use in Examining the Mechanisms of Glucose Action. Hruby, V.J.; Ahn, J-M.; Trivedi, D. // Current Medicinal Chemistry - Immunology, Endocrine & Metabolic ;Nov2001, Vol. 1 Issue 3, p199 

    Glucagon is a crucial hormone in glucose homeostasis and hence has great potential for application to research which seeks to understand its role in normal and diabetic states. Furthermore, antagonists of glucagon, acting at the glucagon receptor, have numerous applications for studying...

  • Subcutaneous Glucagon May Be Better Than Oral Glucose for Prehospital Treatment of Symptomatic Hypoglycemia. Vermeulen, Marian J.; Klompas, Michael; Ray, Joel G.; Mazza, Chris; Morrison, Laurie J. // Diabetes Care;Aug2003, Vol. 26 Issue 8, p2472 

    Reports that subcutaneous glucagon may be better that oral glucose for prehospital treatment of symptomatic hypoglycemia. Comparison of prehospital patient care outcomes following administration of oral glucose gel versus subcutaneous glucagon; Capillary glucose concentration..

  • Glucagon.  // Reactions Weekly;8/13/2011, Issue 1364, p24 

    The article describes the case of an elderly woman who developed a phaeochromocytoma crisis while receiving treatment with glucagon.

  • Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595-2604. Heine, Robert J.; Haoda Fu; Kendall, David M.; Moller, David E. // Diabetes;Oct2013, Vol. 62 Issue 10, pe16 

    A letter to the editor is presented in response to the article "Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors," by A. E. Butler et al. in the 2013 issue...

  • For the Kids. Rawlings, Kelly // Diabetes Forecast;Aug2014, Vol. 67 Issue 8, p9 

    An introduction is presented in which the editor discusses various reports within the issue on topics including one on the improved health outcome for the diabetic patients, the other on self-managed diabetes and the third on glucagon for diabetic students.

  • Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in... Scrocchi, Louise A.; Marshall, Bess A.; Cook, Sonya M.; Brubaker, Patricia L.; Drucker, Daniel J. // Diabetes;Apr1998, Vol. 47 Issue 4, p632 

    Demonstrates a gene dosage effect for the incretin action of glucagon-line peptide-1 (GLP-1). Exhibition of an abnormal glycemic response to oral glucose challenge in association with reduced circulating levels of glucose-stimulated insulin among heterozygous GLP-1R +/- mice; Stimulation of...

  • GETTING TO THE BOTTOM OF LOW BLOOD SUGAR. Dinsmoor, Robert S. // Countdown;Spring2003, Vol. 24 Issue 1, p26 

    Focuses on hypoglycemia, the classic complication of type 1 diabetes. Goal of the Juvenile Diabetes Research Foundation (JDRF) in combating hypoglycemia; Role of glucagon, the counterregulatory pancreatic hormone in helping protect blood sugar levels; Mechanism in which hypoglycemia affects...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics